Integration Clause Does Not Necessarily Extinguish Prior Agreement on Same Patent
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
MOLON MOTOR AND COIL CORP. v. NIDEC MOTOR CORPORATION
Before Lourie, Reyna, and Hughes. Appeal from U.S. District Court for the Northern District of Illinois.
Summary: In interpreting an integration clause that nullifies all prior agreements on the same subject matter, the court will look at factors such as type of license, scope of market, number of patents, and types of products, to determine what is the same subject matter.
In 2006, Molon granted Merkle-Korff a covenant not to sue on two patents. In 2007, Merkle-Korff entered an exclusive license agreement with Molon covering the same two patents, but within a narrowly defined market scope. The 2007 Agreement contained an integration clause that said all prior agreements “concerning the subject matter hereof, are merged herein and shall be of no further force or effect.” Molon later filed a patent infringement suit against Nidec, Merkle-Korff’s successor in interest to the patents, for practicing a licensed patent outside the licensed market.
The district court found the two agreements did not concern the same subject matter and thus the integration clause of the 2007 Settlement did not extinguish the 2006 Covenant. The Federal Circuit affirmed. Although both agreements included the asserted patent, the agreements concerned different subject matter because of differences in the types of rights granted, scope of market, number of patents, and types of products included in each agreement.
Judge Reyna dissented, finding that both agreements related to sufficiently related subject matter, i.e., the right to practice the relevant patent.
Editor: Paul Stewart
Written by: Lindsay Laddaran & Mark Kachner
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…